This defect is most common in the Promus and Ion devices made by Boston Scientific, the agency said. Factors that increase the risk for the complication include calcification of coronary arteries, implantation in a twisted blood vessel and improper positioning of the stent.
Related Articles on Medical Devices:
FDA’s Dr. Jeffrey Shuren Speaks to Congress About Medical Device Approval
Consumers Union Asks Congress to Strengthen Medical Device Oversight
FDA Opens Comment Period on Device Reclassification Process
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.